Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 AUD | -8.33% | -12.00% | -4.35% |
Mar. 26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
Mar. 20 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Business Summary
Number of employees: 27
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Development
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +37.22% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +37.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Baker
CEO | Chief Executive Officer | - | 20-01-01 |
Tim Luscombe
DFI | Director of Finance/CFO | - | Nov. 30 |
Michelle Long
ADM | Chief Administrative Officer | - | - |
Chief Operating Officer | - | 23-01-03 | |
Mini Bharathan
PRN | Corporate Officer/Principal | - | 22-01-31 |
Deborah Cooper
PRN | Corporate Officer/Principal | - | - |
Phillip Hains
SEC | Corporate Secretary | 64 | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 62 | 22-06-30 |
Elizabeth Stoner
BRD | Director/Board Member | 73 | 21-11-09 |
Thomas Duthy
CHM | Chairman | - | 23-03-12 |
Michael Baker
CEO | Chief Executive Officer | - | 20-01-01 |
Debora Barton
BRD | Director/Board Member | 48 | 21-08-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 909,628,062 | 831,895,931 ( 91.45 %) | 0 | 91.45 % |
Company contact information
Arovella Therapeutics Ltd.
62 Lygon Street Level 3, Suite 1
3053, Carlton South
+61 3 9863 6472
http://www.arovella.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.35% | 83.45M | |
+28.79% | 49.18B | |
+0.76% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.18% | 26.09B | |
-22.50% | 18.71B | |
+8.11% | 13.26B | |
+32.17% | 12.32B | |
-0.43% | 11.99B |
- Stock Market
- Equities
- ALA Stock
- Company Arovella Therapeutics Limited